229 related articles for article (PubMed ID: 15967105)
1. Tumor vessel compression hinders perfusion of ultrasonographic contrast agents.
Galiè M; D'Onofrio M; Montani M; Amici A; Calderan L; Marzola P; Benati D; Merigo F; Marchini C; Sbarbati A
Neoplasia; 2005 May; 7(5):528-36. PubMed ID: 15967105
[TBL] [Abstract][Full Text] [Related]
2. Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging.
Yankeelov TE; Niermann KJ; Huamani J; Kim DW; Quarles CC; Fleischer AC; Hallahan DE; Price RR; Gore JC
J Ultrasound Med; 2006 Apr; 25(4):487-97. PubMed ID: 16567438
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
[TBL] [Abstract][Full Text] [Related]
5. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Niermann KJ; Fleischer AC; Huamani J; Yankeelov TE; Kim DW; Wilson WD; Hallahan DE
J Ultrasound Med; 2007 Jun; 26(6):749-56. PubMed ID: 17526606
[TBL] [Abstract][Full Text] [Related]
6. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model.
Pollard RE; Sadlowski AR; Bloch SH; Murray L; Wisner ER; Griffey S; Ferrara KW
Technol Cancer Res Treat; 2002 Dec; 1(6):459-70. PubMed ID: 12625773
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model.
Marzola P; Degrassi A; Calderan L; Farace P; Crescimanno C; Nicolato E; Giusti A; Pesenti E; Terron A; Sbarbati A; Abrams T; Murray L; Osculati F
Clin Cancer Res; 2004 Jan; 10(2):739-50. PubMed ID: 14760097
[TBL] [Abstract][Full Text] [Related]
8. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
Pysz MA; Foygel K; Panje CM; Needles A; Tian L; Willmann JK
Invest Radiol; 2011 Mar; 46(3):187-95. PubMed ID: 21150790
[TBL] [Abstract][Full Text] [Related]
9. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
11. High Frame Rate Contrast-Enhanced Ultrasound Imaging for Slow Lymphatic Flow: Influence of Ultrasound Pressure and Flow Rate on Bubble Disruption and Image Persistence.
Zhu J; Lin S; Leow CH; Rowland EM; Riemer K; Harput S; Weinberg PD; Tang MX
Ultrasound Med Biol; 2019 Sep; 45(9):2456-2470. PubMed ID: 31279503
[TBL] [Abstract][Full Text] [Related]
12. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
[TBL] [Abstract][Full Text] [Related]
13. Gd-encapsulated carbonaceous dots for accurate characterization of tumor vessel permeability in magnetic resonance imaging.
Wu Y; Yan Y; Gao X; Yang L; Li Y; Guo X; Xie J; Wang K; Sun X
Nanomedicine; 2019 Oct; 21():102074. PubMed ID: 31376571
[TBL] [Abstract][Full Text] [Related]
14. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
[TBL] [Abstract][Full Text] [Related]
15. Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation.
Eichhorn ME; Klotz LV; Luedemann S; Strieth S; Kleespies A; Preissler G; Lindner M; Jauch KW; Reiser MF; Clevert DA
Cancer Biol Ther; 2010 May; 9(10):794-802. PubMed ID: 20234173
[TBL] [Abstract][Full Text] [Related]
16. Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound.
Hoyt K; Sorace A; Saini R
Invest Radiol; 2012 Mar; 47(3):167-74. PubMed ID: 22104962
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
18. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
19. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
20. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
